Subscribe
e.g. organoids

VBI Vaccines Receives US FDA Orphan Drug Designation for VBI-1901 for the Treatment of Glioblastoma

VBI Vaccines Inc. announced that the US FDA granted Orphan Drug Designation for VBI-1901, a bivalent gB/pp65 immunotherapeutic vaccine candidate for the treatment of glioblastoma.
[VBI Vaccines Inc.]
Press Release
Published In
NewslettersNeural Cell News
spot_img

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News

The E3 Ligase HERC5 Promotes Antimycobacterial Responses in Macrophages by ISGylating the Phosphatase PTEN

[Science Signaling] Investigators explored the role of ISGylation in the macrophage response to infection with Mycobacterium tuberculosis.
Immunology of Infectious Disease NewsNewsletters
Read more

GC-MSC-Derived circ_0024107 Promotes Gastric Cancer Cell Lymphatic Metastasis via Fatty Acid Oxidation Metabolic Reprogramming Mediated by the miR-5572/6855–5p/CPT1A Axis

[Oncology Reports] The expression profiles of circRNAs and mRNAs were compared between gastric cancer‑MSCs and bone marrow‑derived MSCs using microarray analysis.
Mesenchymal Cell NewsNewsletters
Read more

Prognostic Implications of the Immunohistochemical Expression of Perilipin 1 and Adipophilin in High-Grade Liposarcoma

[Journal Of Clinical Pathology] Scientists evaluated the association between perilipin 1 or adipophilin expression and prognosis in liposarcoma. 97 primary resection specimens were examined.
Mesenchymal Cell NewsNewsletters
Read more
Brought to you by